TerminatedPHASE1, PHASE2NCT05243641
Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test
Studying Hereditary breast cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Rachel LaymanM.D. Anderson Cancer Center
- Intervention
- Neratinib(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2024
Study locations (1)
- M D Anderson Cancer Center, Houston, Texas, United States
Collaborators
Celcuity Inc · Novartis · Puma Biotechnology, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05243641 on ClinicalTrials.govOther trials for Hereditary breast cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07558733Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerFaeth Therapeutics
- RECRUITINGNANCT07436312Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerGustave Roussy, Cancer Campus, Grand Paris
- RECRUITINGNANCT07307664Increasing Germline Genetic Testing for Patients With CancerJosh Peterson
- RECRUITINGNCT07532434A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian CancerPeking University Third Hospital
- RECRUITINGNANCT07292246A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)Vasileios Kalles
- RECRUITINGPHASE2NCT07162298Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer PatientsFirst Affiliated Hospital of Zhejiang University
- RECRUITINGNANCT06760507Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsEmory University
- RECRUITINGNANCT05898009Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2Centre Hospitalier Universitaire de la Réunion